Literature DB >> 10741815

A comparison of pain rating scales by sampling from clinical trial data.

E K Breivik1, G A Björnsson, E Skovlund.   

Abstract

OBJECTIVE: The goals of this study were to examine agreement and estimate differences in sensitivity between pain assessment scales.
DESIGN: Multiple simultaneous pain assessments by patients in acute pain after oral surgery were used to compare a four-category verbal rating scale (VRS-4) and an 11-point numeric rating scale (NRS-11) with a 100-mm visual analog scale (VAS). The sensitivity of the scales (i.e., their ability [power] to detect differences between treatments) was compared in a simulation model by sampling from true pairs of observations using varying treatment differences of predetermined size.
RESULTS: There was considerable variability in VAS scores within each VRS-4 or NRS-11 category both between patients and for repeated measures from the same patient. Simulation experiments showed that the VAS was systematically more powerful than the VRS-4 in all simulations performed. The sensitivity of the VAS and NRS-11 was approximately equal.
CONCLUSIONS: In this acute pain model, the VRS-4 was less sensitive than the VAS. The simulation results demonstrated similar sensitivity of the NRS-11 and VAS when comparing acute postoperative pain intensity. The choice between the VAS and NRS-11 can thus be based on subjective preferences.

Entities:  

Mesh:

Year:  2000        PMID: 10741815     DOI: 10.1097/00002508-200003000-00005

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  138 in total

1.  [Expert assessment of peripheral nerve damage--evaluation of pain syndromes].

Authors:  F Kohl
Journal:  Schmerz       Date:  2002-04       Impact factor: 1.107

2.  American Sign Language and end-of-life care: research in the deaf community.

Authors:  Barbara Allen; Nancy Meyers; John Sullivan; Melissa Sullivan
Journal:  HEC Forum       Date:  2002-09

3.  Postoperative Pain after Treatment Using the GentleWave System: A Randomized Controlled Trial.

Authors:  Daryl Grigsby; Ronald Ordinola-Zapata; Scott B McClanahan; Alex Fok
Journal:  J Endod       Date:  2020-06-14       Impact factor: 4.171

4.  Demographic and clinical characteristics associated with quality of life in patients with chronic obstructive pulmonary disease.

Authors:  Signe Berit Bentsen; Christine Miaskowski; Tone Rustøen
Journal:  Qual Life Res       Date:  2013-09-03       Impact factor: 4.147

5.  Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adults.

Authors:  Samer S El-Kamary; Melissa Billington; Stephen Deitz; Elaina Colby; Howard Rhinehart; Yukun Wu; William Blackwelder; Robert Edelman; Albert Lee; Alan King
Journal:  Mol Ther       Date:  2011-11-08       Impact factor: 11.454

6.  Preservation of upper limb function following spinal cord injury: a clinical practice guideline for health-care professionals.

Authors: 
Journal:  J Spinal Cord Med       Date:  2005       Impact factor: 1.985

7.  External coxa saltans (snapping hip) treated with Active Release Techniques: a case report.

Authors:  Andreo A Spina
Journal:  J Can Chiropr Assoc       Date:  2007-03

Review 8.  Uniformity of Chronic Pain Assessment after Inguinal Hernia Repair: A Critical Review of the Literature.

Authors:  Marijke Molegraaf; Johan Lange; Arthur Wijsmuller
Journal:  Eur Surg Res       Date:  2016-08-27       Impact factor: 1.745

9.  Intraoperative Arthroscopic Cold Irrigation Solution Does Not Affect Postoperative Pain and Swelling.

Authors:  A Louise Fincher; G William Woods; Daniel P. O'Connor
Journal:  J Athl Train       Date:  2004-03       Impact factor: 2.860

10.  Agreement between electronic medical record-based and self-administered pain numeric rating scale: clinical and research implications.

Authors:  Joseph L Goulet; Cynthia Brandt; Stephen Crystal; David A Fiellin; Cynthia Gibert; Adam J Gordon; Robert D Kerns; Stephen Maisto; Amy C Justice
Journal:  Med Care       Date:  2013-03       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.